Sjögren Syndrome: A Forgotten or an Overdiagnosed Entity?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37914214.
- Also identified by DOI 10.3899/jrheum.2023-0964.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this issue of <i>The Journal of Rheumatology</i>, Lee et al present an interesting editorial claiming that seronegative Sjögren syndrome (SS) is a forgotten entity.<sup>1</sup> They provide convincing arguments supporting this assertion. As reminded by the authors, it is crucial to distinguish patients with seronegative SS from patients living with sicca symptoms, because the former group may experience potentially serious extraglandular manifestations, and thus require entirely different therapeutic approaches than patients with sicca symptoms without any autoimmune disorders.